Market Tracker

10/20 5:16pm ET

Inspyr Therapeutics Inc (OTCQB:NSPX)

0.09
Delayed Data
As of Oct 20
 +0.0071 / +8.56%
Today’s Change
0.06
Today|||52-Week Range
4.99
-83.64%
Year-to-Date
No recent news for Inspyr Therapeutics Inc.

Today’s Trading

Previous close0.08
Today’s open0.09
Day’s range0.09 - 0.09
Volume10,000
Average volume (3 months)17,403
Market cap$787.1K
Dividend yield--
Data as of 1:08pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, CAO &
Executive Director
Christopher P. Lowe
Chief Medical Officer &
Senior Vice President
Ronald L. Shazer
Corporate headquarters
Westlake Village, California

Forecasts